Evidence map›Paper›PMID 32309807›Full record

ArticleAdvances in pharmacological and pharmaceutical sciences2020

The Class III PI3K/Beclin-1 Autophagic Pathway Participates in the mmLDL-Induced Upregulation of ET

Xi Xie, Chen Chen, Cang-Bao Xu, Jie Lin, Lei Cao, Gen Chen, Jie Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in pharmacological and pharmaceutical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Programmed Cell Death in Diabetic Nephropathy: A Review of Apoptosis, Autophagy, and Necroptosis.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xi XieThe First People's Hospital of Chenzhou, Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China.
Chen ChenThe First People's Hospital of Chenzhou, Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China.
Cang-Bao XuShaanxi Key Laboratory of Ischemic Cardiovascular Disease, Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, China.ORCID https://orcid.org/0000-0003-3421-3306
Jie LinThe First People's Hospital of Chenzhou, Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China.
Lei CaoDepartment of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.ORCID https://orcid.org/0000-0003-0253-5247
Gen ChenThe First People's Hospital of Chenzhou, Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China.
Jie LiThe First People's Hospital of Chenzhou, Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China.ORCID https://orcid.org/0000-0002-9411-6623
First Affiliated Hospital of University of South China · CNXi'an Jiaotong University · CNXi'an Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Minimally modified low-density lipoprotein (mmLDL) is a risk factor for cardiovascular diseases. The current study explored the effect of mmLDL on the endothelin type A (ETA) receptor in mouse mesenteric arteries

Identifiers

PMID32309807
PMCPMC7152935
OpenAlexW3014093632

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.